C-terminus of p53 is required for G2 arrest

被引:15
作者
Nakamura, S
Gomyo, Y
Roth, JA
Mukhopadhyay, T
机构
[1] Univ Texas, MD Anderson Canc Ctr, Sect Thorac Mol Oncol, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Tumor Biol, Houston, TX 77030 USA
关键词
p53; p21; G(2) arrest;
D O I
10.1038/sj.onc.1205251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutation of four lysine residues in the p53 C-terminal domain inhibits MDM2-dependent ubiquitination of p53 and alters its subcellular distribution. This implies that modification (such as acetylation and phosphorylation) of amino acid residues in p53 C-terminal domain, regulate the biological functions of p53. In this study, we demonstrated that p53 with lysine residues 372, 373, 381, and 382 mutated to alanine (the A4 mutant) retained the transactivation activity of wild-type p53, although the transactivation activity of p21 promoter by the A4 mutant was slightly reduced. The inducible expression of wild-type p53 and the A4 mutant in H1299 cells caused growth inhibition due to cell-cycle arrest. Consistent with previous studies, the expression of wild-type p53 elicited G(1) and G(2) arrests. However, the cells expressing the A4 mutant underwent G(1) arrest but not G(2) arrest. Cyclin B1-associated kinase activity was reduced in cells expressing wild-type p53 but not A4, when the cells underwent G(2) arrest. This suggests that modification of the p53 C-terminal domain might inhibit p53-mediated G(2) arrest. In other words, p53 requires an intact C-terminus to induce G(2) arrest.
引用
收藏
页码:2102 / 2107
页数:6
相关论文
共 31 条
[1]   P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS [J].
AGARWAL, ML ;
AGARWAL, A ;
TAYLOR, WR ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8493-8497
[2]   Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage [J].
Chehab, NH ;
Malikzay, A ;
Stavridi, ES ;
Halazonetis, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13777-13782
[3]   p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells [J].
Chen, XB ;
Ko, LJ ;
Jayaraman, L ;
Prives, C .
GENES & DEVELOPMENT, 1996, 10 (19) :2438-2451
[4]   TUMOR SUPPRESSORS, KINASES AND CLAMPS - HOW P53 REGULATES THE CELL-CYCLE IN RESPONSE TO DNA-DAMAGE [J].
COX, LS ;
LANE, DP .
BIOESSAYS, 1995, 17 (06) :501-508
[5]   p53 in growth control and neoplasia [J].
Gottlieb, TM ;
Oren, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :77-102
[6]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606
[7]  
HARPER JW, 1993, CELL, V75, P805
[8]   CHECKPOINTS - CONTROLS THAT ENSURE THE ORDER OF CELL-CYCLE EVENTS [J].
HARTWELL, LH ;
WEINERT, TA .
SCIENCE, 1989, 246 (4930) :629-634
[9]   Cell type-specific inhibition of p53-mediated apoptosis by mdm2 [J].
Haupt, Y ;
Barak, Y ;
Oren, M .
EMBO JOURNAL, 1996, 15 (07) :1596-1606
[10]   14-3-3σ is a p53-regulated inhibitor of G2/M progression [J].
Hermeking, H ;
Lengauer, C ;
Polyak, K ;
He, TC ;
Zhang, L ;
Thiagalingam, S ;
Kinzler, KW ;
Vogelstein, B .
MOLECULAR CELL, 1997, 1 (01) :3-11